Reglan Lawsuit

Designed to treat disorders such as heartburn caused by gastroesophageal reflux, Reglan (generic: metoclopramide) has been linked to the development of a serious condition, tardive dyskinesia. Tardive dyskinesia is a movement disorder that is marked by uncontrolled, involuntary muscle movements.

If you or a loved one has developed tardive dyskinesia while using Reglan, you may be eligible to seek and recover compensation for the injuries and losses incurred through a Reglan lawsuit. Chaffin Luhana LLP is a national law firm, designed to provide aggressive and committed representation for injured consumers across the country. To discuss the unique circumstances of your potential Reglan tardive dyskinesia case, contact a Reglan lawyer at Chaffin Luhana LLP today.

Reglan Side Effects: Tardive Dyskinesia

People with tardive dyskinesia will experience involuntary movements in their muscles. Symptoms may include one or more of the following uncontrolled movements:

  • Lip smacking
  • Facial grimacing
  • Rapid tongue thrusting
  • Rapid blinking, eye bulging
  • Puckering or pursing of the lips
  • Uncontrolled movements of the fingers

Symptoms may or may not subside once a patient discontinues use of the drug. According to reports, people with the highest risk of developing tardive dyskinesia include those who take Reglan for long periods of time, women and the elderly.

Reglan FDA Warning

The U.S. Food and Drug Administration (FDA) issued an alert to physicians, advising them against long-term use of metoclopramide. According to the agency, the drug is only approved for short-term use, as the higher the dose and the longer the use increases a patient’s risk of injury. The FDA estimates that approximately 2 million people have already used Reglan; that number is expected to continue to increase, putting many more Americans at risk.

In response to the mounting reports of Reglan-caused tardive dyskinesia, in February 2009, the FDA required manufacturers of metoclopramide to add a boxed warning to their drug labels. The boxed warning is to alert consumers of the risk associated with high-dose and long-term Reglan use. The FDA requires boxed warnings to ensure consumers and physicians understand the potential health risks associated with certain drugs. Consumers and their physicians can then make informed decisions about their treatment options.

Reglan Lawyers: Chaffin Luhana LLP

Have you or a loved one been diagnosed with tardive dyskinesia following a Reglan treatment? If so, contact a Reglan lawyer at Chaffin Luhana LLP toll-free at 888-480-1123, or via email, to see if qualify for a Reglan lawsuit. We represent injured Reglan consumers nationwide. We are ready to investigate the details of your potential claims and will aggressively on your behalf.